TINH NGUYEN: Open Payments
NPI 1265579296 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,154 in 27 payments from 11 companies in 2025. Trend: 2023 $1,230 · 2024 $1,379 · 2025 $1,154
Food & beverage: $1,154
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $344 |
| Novo Nordisk Inc | 5 | $240 |
| Exact Sciences Corporation | 3 | $152 |
| Abbott Laboratories | 1 | $144 |
| Gilead Sciences, Inc. | 3 | $68 |
| ABIOMED | 2 | $64 |
| Bausch Health US, LLC | 3 | $54 |
| Amgen Inc. | 2 | $34 |
| Lilly USA, LLC | 1 | $21 |
| OWP Pharmaceuticals, Inc. | 1 | $17 |
Products named: AIRSUPRA, Ozempic, AVEIR, FARXIGA, APLENZIN, OTEZLA, Wegovy, KISUNLA.
Industry payments across TX — which companies pay providers there.
